Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 14.6214.5313.9611.0922.79

What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS is 14.62 based on Mar2026 Standalone results.
Year EV/Core EBITDA
Mar202614.62
Mar202514.53
Mar202413.96
Mar202311.09
Mar202222.79

How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 14.62
0.62
Mar2025 14.53
4.08
Mar2024 13.96
25.88
Mar2023 11.09
-51.34
Mar2022 22.79 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹1,068.8 Cr 8.2% 48.8% 293% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,620.0 Cr -0.2% -5.1% 8.4% Stock Analytics
DIVIS LABORATORIES ₹239,714.0 Cr -3.8% -3.2% 51.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,741.0 Cr -1.7% -7.7% 29.9% Stock Analytics
CIPLA ₹106,061.0 Cr 0.6% -3.8% -11% Stock Analytics
DR REDDYS LABORATORIES ₹101,339.0 Cr 2.9% 4.6% 0.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

8.2%

48.8%

293%

SENSEX

0.2%

-2.8%

-11.2%


You may also like the below Video Courses